Semaglutide Reduces Medical Costs: One-Year Economic Impact Analysis
One-year analysis shows semaglutide reduces total medical costs in obese patients through fewer hospitalizations, ER visits, and complications despite high drug cost.
Quick Facts
What This Study Found
One-year analysis shows semaglutide reduces total medical costs in obese patients through fewer hospitalizations, ER visits, and complications despite high drug cost.
Key Numbers
Semaglutide 2.4 mg once weekly. Costs evaluated excluding pharmacy. Patients had obesity or overweight with ≥1 obesity-related complication.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding One-year analysis shows semaglutide reduces total medical costs in obese patients through fewer hosp
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Effects of semaglutide on one-year medical costs among patients with obesity or overweight in US real world setting.
- Published In:
- Expert review of pharmacoeconomics & outcomes research, 25(9), 1345-1355 (2025)
- Authors:
- Arora, Prachi(2), Michalak, Wojciech(3), Zhao, Zhenxiang(3), Fiasconaro, Megan, Hong, Yu, Zhao, Xin, Ó Hartaigh, Bríain, Alvarez, Sara, Fitch, Angela
- Database ID:
- RPEP-09983
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
One-year analysis shows semaglutide reduces total medical costs in obese patients through fewer hospitalizations, ER visits, and complications despite high drug cost.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09983APA
Arora, Prachi; Michalak, Wojciech; Zhao, Zhenxiang; Fiasconaro, Megan; Hong, Yu; Zhao, Xin; Ó Hartaigh, Bríain; Alvarez, Sara; Fitch, Angela. (2025). Effects of semaglutide on one-year medical costs among patients with obesity or overweight in US real world setting.. Expert review of pharmacoeconomics & outcomes research, 25(9), 1345-1355. https://doi.org/10.1080/14737167.2025.2570688
MLA
Arora, Prachi, et al. "Effects of semaglutide on one-year medical costs among patients with obesity or overweight in US real world setting.." Expert review of pharmacoeconomics & outcomes research, 2025. https://doi.org/10.1080/14737167.2025.2570688
RethinkPeptides
RethinkPeptides Research Database. "Effects of semaglutide on one-year medical costs among patie..." RPEP-09983. Retrieved from https://rethinkpeptides.com/research/arora-2025-effects-of-semaglutide-on
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.